Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Statistics

Total Valuation

SHE:301089 has a market cap or net worth of CNY 4.39 billion. The enterprise value is 4.12 billion.

Market Cap	4.39B
Enterprise Value	4.12B

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	May 23, 2024

Share Statistics

SHE:301089 has 126.54 million shares outstanding. The number of shares has increased by 6.46% in one year.

Current Share Class	126.54M
Shares Outstanding	126.54M
Shares Change (YoY)	+6.46%
Shares Change (QoQ)	+19.96%
Owned by Insiders (%)	54.78%
Owned by Institutions (%)	1.65%
Float	57.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.71
PB Ratio	2.84
P/TBV Ratio	2.99
P/FCF Ratio	n/a
P/OCF Ratio	195.22
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-161.32
EV / Sales	10.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-72.71

Financial Position

The company has a current ratio of 4.14, with a Debt / Equity ratio of 0.00.

Current Ratio	4.14
Quick Ratio	2.73
Debt / Equity	0.00
Debt / EBITDA	7.33
Debt / FCF	-0.06
Interest Coverage	-505.99

Financial Efficiency

Return on equity (ROE) is -1.62% and return on invested capital (ROIC) is -1.88%.

Return on Equity (ROE)	-1.62%
Return on Assets (ROA)	-1.66%
Return on Invested Capital (ROIC)	-1.88%
Return on Capital Employed (ROCE)	-2.98%
Revenue Per Employee	264,582
Profits Per Employee	-16,453
Employee Count	1,551
Asset Turnover	0.23
Inventory Turnover	1.55

Taxes

Income Tax	-8.63M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.95% in the last 52 weeks. The beta is -0.79, so SHE:301089's price volatility has been lower than the market average.

Beta (5Y)	-0.79
52-Week Price Change	+21.95%
50-Day Moving Average	33.02
200-Day Moving Average	30.61
Relative Strength Index (RSI)	57.64
Average Volume (20 Days)	8,125,060

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301089 had revenue of CNY 410.37 million and -25.52 million in losses. Loss per share was -0.20.

Revenue	410.37M
Gross Profit	113.57M
Operating Income	-47.40M
Pretax Income	-34.15M
Net Income	-25.52M
EBITDA	128,802
EBIT	-47.40M
Loss Per Share	-0.20

Balance Sheet

The company has 281.50 million in cash and 3.28 million in debt, giving a net cash position of 278.21 million or 2.20 per share.

Cash & Cash Equivalents	281.50M
Total Debt	3.28M
Net Cash	278.21M
Net Cash Per Share	2.20
Equity (Book Value)	1.55B
Book Value Per Share	12.24
Working Capital	508.73M

Cash Flow

In the last 12 months, operating cash flow was 22.51 million and capital expenditures -79.13 million, giving a free cash flow of -56.62 million.

Operating Cash Flow	22.51M
Capital Expenditures	-79.13M
Free Cash Flow	-56.62M
FCF Per Share	-0.45

Margins

Gross margin is 27.68%, with operating and profit margins of -11.55% and -6.22%.

Gross Margin	27.68%
Operating Margin	-11.55%
Pretax Margin	-8.32%
Profit Margin	-6.22%
EBITDA Margin	0.03%
EBIT Margin	-11.55%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.72%.

Dividend Per Share	0.25
Dividend Yield	0.72%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.46%
Shareholder Yield	-5.74%
Earnings Yield	-0.58%
FCF Yield	-1.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHE:301089 has an Altman Z-Score of 13.02 and a Piotroski F-Score of 4.

Altman Z-Score	13.02
Piotroski F-Score	4